Thermodynamic properties at the kinetic freeze-out in the Au + Au and Cu + Cu collisions at the RHIC using the Tsallis distribution
Not provided.
SEARCH · Engineering Papers
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Not provided.
Highlights: • E41K mutation inhibits the “off”/”on” transition of the thin filaments. • Myosin heads lose ability to shift E41K-Tpm in the open position at high Ca{sup 2+}. • E41K-Tpm is shifted towards the blocked position during the ATPase cycle. • Switching on and off of actin monomers at high and low Ca{sup 2+} is inhibited. • Mutation inhibits the growth of the fraction of strongly bound S1 at high Ca{sup 2+}. The E41K mutation in TPM2 gene encoding muscle regulatory protein beta-tropomyosin is associated with nemaline myopathy and cap disease. The mutation results in a reduced Ca{sup 2+}-sensitivity of the thin filaments and in muscle weakness. To elucidate the structural basis of the reduced Ca{sup 2+}-sensitivity of the thin filaments, we studied multistep changes in spatial arrangement of tropomyosin (Tpm), actin and myosin heads during the ATPase cycle in reconstituted fibers, using the polarized fluorescence microscopy. The E41K mutation inhibits troponin's ability to shift Tpm to the closed position at high Ca{sup 2+}, thus restraining the transition of the thin filaments from the “off” to the “on” state. The mutation also inhibits the ability of S1 to shift Tpm to the open position, decreases the amount of the myosin heads bound strongly to actin at high Ca{sup 2+}, but increases the number of such heads at low Ca{sup 2+}. These changes may contribute to the low Ca{sup 2+}-sensitivity and muscle weakness. As the mutation has no effect on troponin's ability to switch actin monomers on at high Ca{sup 2+} and inhibits their switching off at low Ca{sup 2+}, the use of reagents that increase the Ca{sup 2+}-sensitivity of the troponin complex may not be appropriate to restore muscle function in patients with this mutation.
Not Available
Not Available
Not Available
Not Available